News January 10, 2014 NHLBI funding opportunity announcements, Jan. 9, 2014 Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components… Super User 0 Love0
News January 10, 2014 National Innovation Summit & Showcase – June 15-19, 2014 The National SBIR Conference and the 3rd annual National Innovation Summit and Showcase will be… Super User 0 Love0
News January 10, 2014 Maryland Startup CoFoundersLab Claims a Crowdfunding First – Venture Capital Dispatch – WSJ Last Sept. 22, the chief executive of a startup called CoFoundersLab Inc., Shahab Kaviani, sat… Super User 0 Love0
News January 10, 2014 Patently Biotech’s Top Articles of 2013 – BIOtechNow Intellectual property featured prominently in 2013’s public discourse. Gene patents, patent trolls, India’s anti-patent actions,… Super User 0 Love0
News January 10, 2014 New director named for Arundel tech incubator – baltimoresun.com Anne Arundel County Executive Laura Neuman has appointed a Brooklyn Park woman to a job… Super User 0 Love0
News January 10, 2014 GSK Gets Accelerated FDA Approval for Melanoma Drug Combo GlaxoSmithKline plc announced that the U.S. Food and Drug Administration (FDA) has approved Mekinist (trametinib)… Super User 0 Love0
News January 10, 2014 WellDoc Closes $20 Million in Strategic Financing – Business Wire WellDoc®, developers of the first FDA cleared mobile prescription therapy, BlueStarTM, announced today that it… Super User 0 Love0
News January 10, 2014 Johnson & Johnson Innovation expands global incubator presence to Israel – Pharmaceutical Business Review Johnson & Johnson Innovation has announced that it is expanding its global incubator presence through… Super User 0 Love0
News January 10, 2014 MedImmune in £multi million deal to strike cancer AstraZeneca today announced that Granta Park-based MedImmune, its global biologics research and development arm, has… Super User 0 Love0
News January 10, 2014 Intrexon Corporation – Synthetic Biology through Better DNA – Investor Relations – Newsroom Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has entered… Super User 0 Love0